z-logo
open-access-imgOpen Access
Safety and efficacy of a pharmaco-invasive reperfusion strategy in rural ST-elevation myocardial infarction patients with expected delays due to long-distance transfers
Author(s) -
David M. Larson,
Sue Duval,
Scott W. Sharkey,
Ross Garberich,
James D. Madison,
Peter J. Stokman,
T. Dirks,
R. K. Westin,
James L. Harris,
Timothy D. Henry
Publication year - 2011
Publication title -
european heart journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.336
H-Index - 293
eISSN - 1522-9645
pISSN - 0195-668X
DOI - 10.1093/eurheartj/ehr403
Subject(s) - medicine , conventional pci , percutaneous coronary intervention , myocardial infarction , clopidogrel , reperfusion therapy , timi , cardiology , fibrinolysis , aspirin , st elevation , fibrinolytic agent , emergency medicine , tissue plasminogen activator
To determine the safety and efficacy of a pharmaco-invasive reperfusion strategy utilizing half-dose fibrinolysis combined with transfer for immediate percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction (STEMI) patients presenting to remote rural hospitals. Primary PCI is preferred for STEMI if performed in a timely manner. However, <20% of STEMI patients transferred for PCI in the USA have door-to-balloon times <2 h.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom